The Central Drugs Standard Control Organisation's Subject Expert Committee (SEC) will be holding a meeting later today (Wednesday) to decide on approving the Covishield vaccine against Covid-19 developed by the Serum Institute of India (SII) and AstraZeneca-Oxford University. The Covishield vaccine is likely to get approval for emergency use in India, said sources.